Dvm360® announces winners of the prestigious Veterinary Heroes® program
06 sept. 2024 09h00 HE
|
dvm360®
CRANBURY, N.J., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Dvm360®, the leading multimedia provider of animal health care communications, education and research for veterinary professionals, is honored to...
Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
06 févr. 2024 08h10 HE
|
Gallant Therapeutics
Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
3D Printing in Veterinary Medicine Market in North America is Expected To Grow With The Highest CAGR to 2031
30 janv. 2024 05h28 HE
|
InsightAce Analytic Pvt. LTd.
Jersey City, NJ, Jan. 30, 2024 (GLOBE NEWSWIRE) -- “3D Printing in Veterinary Medicine Market” poised to expand at a CAGR of 15.8% from 2024 to 2031 according to a new report by InsightAce Analytic....
Companion Animal Health Market to Reach a Valuation of US$ 61.6 Billion by 2033, By Persistence Market Research
16 janv. 2024 06h00 HE
|
Persistence Market Research
New York, Jan. 16, 2024 (GLOBE NEWSWIRE) -- The Companion Animal Health Market encompasses products and services designed to enhance the well-being of companion animals, including dogs, cats, and...
Dvm360® elevates veterinary education and networking: Fetch conference in new location, Nashville, TN
12 janv. 2024 16h27 HE
|
dvm360®
CRANBURY, N.J., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Dvm360®, the leading multimedia provider of animal health care communications, education and research for veterinary professionals, is excited to...
Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets
08 janv. 2024 08h00 HE
|
Gallant Therapeutics
Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of "Off-the-Shelf" Stem Cell Therapies for Pets
Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis
06 déc. 2023 08h19 HE
|
Gallant Therapeutics
Gallant Therapeutics Announces Launch of JEDI Pivotal Study for First Allogeneic Stem Cell Therapy Targeting Feline Chronic Gingivostomatitis
dvm360® and Chewy Health announce the 2023 Innovator of the Year Award™ recipients
04 déc. 2023 09h00 HE
|
dvm360®
CRANBURY, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- dvm360, the number one multimedia platform in the veterinary industry, in partnership with Chewy Health, the dedicated pet health care arm of Chewy,...
North Carolina Budget Includes $70 Million for Large Animal Hospital and New Equine Veterinary Center
09 oct. 2023 08h05 HE
|
North Carolina State College of Veterinary Medicine
RALEIGH, NC, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The NC State College of Veterinary Medicine community is celebrating the inclusion in the state budget of $70 million for expanding and renovating the...
Ethos Discovery and Gallant Therapeutics Collaborate on Study Evaluating Gallant’s Stem Cell Therapy in Pugs with Necrotizing Meningoencephalitis (NME), also referred to as Pug Dog Encephalitis (PDE)
03 oct. 2023 08h12 HE
|
Gallant Therapeutics
Gallant Therapeutics and Ethos Discovery collaborate in a clinical study evaluating the use of stem cells to treat pugs with early-stage NME